AUSTAR Joined 2018 CIPM
From April 20th to 22nd, the 55th (Spring) National Pharmaceutical Machinery Exposition and China International Pharmaceutical Machinery Exposition was held in Chongqing. The products and high-end integrated engineering solutions that covered the whole drug life cycle had been introduced, attracting nearly a thousand participants to stop and focus.
AUSTAR “2018 Technology Forum for Soft Capsule Preparation” Was Held
The "2018 Technology Forum for Soft Capsule Preparation" was held on April 9th at InterContinental Shijiazhuang. Nearly 100 guests gathered together, listened to the experts to analyze the production and process and discussed the core technical topics.
2017 ISPE China in Shanghai Comes to Successfully End
During 4th Nov. to 6th Nov. in 2017, 2017 ISPE China is grandly held in Shanghai organized by China Center for Food and Drug International Exchange (CCFDIE), Center for Food and Drug Inspection of China Food and Drug Administration (CFDI) and International Society for Pharmaceutical Engineering (ISPE). The attendees are comprised of more than 200 Pharmaceutical Companies, and over 800 people came from international and national administration, well-known corporation, Academic Institution and Industry Association.
CIPM 2017 Is Opening in Changsha Today
The 54th China National Pharmaceutical Machinery Exposition 2017 (Autumn) China International Pharmaceutical Machinery Exposition (“CIPM”) is opening in Changsha International Convention and Exhibition Center. CIPM is China’s largest leading show of pharmaceutical industry. It has been held for 53 times since 1991. With 26 years of contributing to Chinese pharmaceutical industry, CIPM has firmly established itself as the industry's must-attend show in China.
Gathered Together in Changsha- AUSTAR Group Invite You to Join CIPM
The 54th China National Pharmaceutical Machinery Exposition 2017 (Autumn) China International Pharmaceutical Machinery Exposition (“CIPM”) will be held in Changsha International Convention and Exhibition Center on Nov.06(Mon)-08(Wed),2017. CIPM is China’s largest leading show of pharmaceutical industry. It has been held 53 times since 1991. With 26 years of contributing to the Chinese pharmaceutical industry, CIPM has firmly established itself as the industries’ must-attend show in China.
“The Second Session of AUSTAR QbD Seminar”Came to A Successful Conclusion
“The Second Session of AUSTAR QbD Seminar” ended successfully in Shanghai Longemont Hotel on September,7th. We invited TLC Company President Dr. Thomas A. Little from the well-known U.S. pharmaceutical industry QbD training and consulting company as the guest speaker. Dr. Little has many years of experience in pharmaceutical industry, and provides training service for more than 100 thousand global researchers, engineers, pharmacists, pharmaceutical and professionals in laws and regulations.
AUSTAR will attend CPhI & P-MEC China 2017
AUSTAR will go to Shanghai for CPhI & P-MEC China on 20-22 June. CPhI is a main event in the pharmaceutical industry throughout Asia.
AUSTAR Pharmaceutical Engineering Forum 2017 Closed
From 18-19 May. AUSTAR Pharmaceutical Engineering Forum 2017 was held in Hangzhou, China. The topic is improving API pharmaceutical manufacturing technology and providing integrated solutions for them.
Austar shows in Biopharma Development & Production 2017
From 15-17 May. 2017, Biopharma Development & Production (BDP) Week held in Hilton Shanghai Hongqiao Hotel.
AUSTAR Group will join CIPM 2017 China
The 53rd China National Pharmaceutical Machinery Exposition 2017 (Spring) (“CIPM”) will be held in Qingdao International Expo Center, on April.19 (Wed.) – 21 (Fri.). CIPM is China’s largest leading show of pharmaceutical industry.
Micronization &Containment Isolation Technology Seminar
The Micronization &Containment Isolation Technology Seminar had finished successfully in Shanghai on 14th, March.
AUSTAR will show in BioCon2017 China
AUSTAR Group will bring our One-stop Solution to participate in BioCon2017 on March, 24th, in Shanghai.
AUSTAR participated in 2017 Enmore Bio Conference
From 22nd to 24th Feb. Austar SIC team was in Enmore Bio Conference (EBC 2017) with their advanced achievements in biological field in Nanjing, China.
Successful Hosting of News Conference on European Latest Filling / Isolation / Lyophilization System
On October 20, 2015, Austar appeared with latest European filling/isolation/lyophilization system in the conference in Nanjing.
Congratulations on United Kingdom Cape for reaching a strategic cooperation agreement with AUSTAR
With the increasingly stringent requirements for 2010 GMP, FDA, EUGMP regulations on sterile pharmaceutical production, confined isolation technology inevitably will provide an effective protection barrier for sterile pharmaceutical production.
Warm congratulations to Hulun Buir Northern Pharmaceutical Co., Ltd for passing on-site inspections by WHO successfully
During the period of July 14 to July 17, 2015, three prosecutors of WHO visited Hulun Buir Northern Pharmaceutical Co., Ltd (hereafter referred to as the Northern Pharmaceutical) to conduct on-site inspections, who focused on the assessment of the improving working of the contamination and cross-contamination of high-activity products, and conducted an detailed inquiry and a on-the-spot investigation on relevant issues.
AUSTAR Makes Its Debut in Qingdao Spring Exhibition with the Strength to Push Pharmaceutical Industry
On May 17, AUSTAR Group brings the full range of the latest products making its debut at the 49th (2015 Spring Exhibition) National Pharmaceutical Machinery Expo and China International Pharmaceutical Machinery Exposition.
AUSTAR Works, Win Awards
Review results of the best publication sharing by the China Petroleum and Chemical Industry Federation have been published recently.
Risk assessment on sealing performance test of high active drug production equipment
In recent years, there are more and more pharmaceutical enterprise for manufacturing of high active drug, and the use of sealing contained equipment are very common in manufacturing of high active drugs. But the sealing performance test of this kind of equipment and how to conduct risk assessment on test process are the relatively confused aspects for many enterprises.
New policy for environmental protection, development of pharmaceutical industry led by green ecology
More and more smoggy days, frequent occurrence of water pollution events, and severe soil contamination; environmental problem has become one of livelihood issues to be solved urgently.